Rocket Doctor AI Inc. (CSE: AIDR | OTC: AIRDF | Frankfurt: 939) has announced it will present at the 2026 CANTech Letter Investment Conference in Toronto, Ontario on October 8, 2026. Founder and CEO of Rocket Doctor Inc., Dr. William Cherniak, will take the stage in Track 2 at 4:00 PM ET for a 30-minute session. The presentation is expected to cover the company's AI-powered healthcare platform, recent milestones, and growth strategy, offering investors a live look at the company's direction.

Key Points

  • Rocket Doctor AI Inc. (CSE: AIDR | OTC: AIRDF | Frankfurt: 939) is a physician-built, AI-powered healthcare technology company based in Vancouver, BC
  • Dr. William Cherniak will present in Track 2 at the 2026 CANTech Letter Conference on October 8, 2026, at 4:00 PM ET
  • The presentation will address platform innovations, recent operational milestones, and the company's growth strategy
  • Investors may be watching for updates on the company's platform expansion and its reach across Canadian and U.S. healthcare markets

Rocket Doctor AI's Scheduled Slot at CANTech 2026

The 2026 CANTech Letter Investment Conference is described in the announcement as a premier annual Toronto event bringing together innovative Canadian companies across technology, healthcare, AI, cybersecurity, and fintech sectors. It attracts institutional and retail investors seeking exposure to emerging Canadian investment ideas. Rocket Doctor AI's session is scheduled for 4:00–4:30 PM ET in Track 2 on October 8, 2026. The release states that attendees can register and access further event details at the conference's official website.

Dr. Cherniak's Remarks on Clinician-Led AI

In the announcement, Dr. Bill Cherniak stated that CANTech brings together Canada's most engaged technology investors and operators, and expressed enthusiasm for sharing how Rocket Doctor AI is deploying clinician-led, pragmatic AI platforms to streamline workflows, reduce administrative friction, and improve patient access and outcomes. The company describes itself as physician-built and notes that its technology has supported over 350 MDs in delivering more than 800,000 patient visits through its digital health platform and marketplace.

Rocket Doctor AI's Platform and Healthcare Focus

According to the release, a cornerstone of Rocket Doctor AI's proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide. The company states its platform enables doctors to independently launch and manage virtual or hybrid in-person practices. The release also notes a focus on serving underserved, rural, and remote communities in Canada, as well as patients on Medicaid and Medicare in the United States, using advanced AI and large language models.